GBS(US:INBS) Globenewswireยท2025-05-22 12:30Core Insights - Intelligent Bio Solutions Inc. (INBS) will participate in the RISE25 conference, focusing on addiction, mental health, and justice innovation, which attracts over 7,000 attendees annually [1][3] - The company aims to showcase its Intelligent Fingerprinting Drug Testing Solution, which is currently utilized in the U.S. for forensic purposes through its partnership with SMARTOX [1][2] Company Overview - INBS is a medical technology company specializing in rapid, non-invasive testing solutions, with over 450 active accounts across 24 countries [1][4] - The Intelligent Fingerprinting Drug Screening System detects recent drug use through fingerprint sweat, providing results in under ten minutes, making it suitable for treatment courts and probation programs [2][6] Market Context - RISE25 serves as a national platform for professionals in public health and justice, focusing on evidence-based approaches for individuals affected by substance use and mental health issues [3][4] - The U.S. market for forensic use of drug testing presents significant expansion opportunities for INBS, which believes its technology can deliver substantial benefits in this sector [4] Strategic Partnerships - INBS collaborates with SMARTOX, a U.S.-based provider of drug and alcohol testing products, to enhance its market presence and support innovative solutions in various sectors [5][6] - The partnership aims to address the growing demand for reliable on-site drug testing solutions across workplaces, treatment facilities, and the justice system [1][4]